Early results of minimally invasive mitral valve surgery: initial series in a public hospital in Australia

2010 ◽  
Vol 58 (11) ◽  
pp. 568-572 ◽  
Author(s):  
Tadashi Kitamura ◽  
James Edwards ◽  
Michael Worthington ◽  
Kaushalendra S. Rathore ◽  
Manoranjan Misra ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Public Hospital ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Initial Series ◽  
Early Results

Three-dimensional Video Assistance Improves Early Results in Minimally Invasive Mitral Valve Surgery

ASAIO Journal ◽  
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Eilon Ram ◽  
Yaron Moshkovitz ◽  
Ami Shinfeld ◽  
Alexander Kogan ◽  
Yael Peled ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Three Dimensional ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Early Results

Myocardial Protection Using HTK Solution in Minimally Invasive Mitral Valve Surgery

2005 ◽  
Vol 8 (1) ◽  
pp. 25 ◽  
Author(s):  
C. Savini ◽  
N. Camurri ◽  
A. Castelli ◽  
A. Dell'Amore ◽  
D. Pacini ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Myocardial Protection ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Coronary Perfusion ◽  
Aortic Cross Clamp ◽  
Early Results ◽  
Htk Solution ◽  
The Mean

Background: Minimally invasive cardiac surgery (MICS) is a safe and satisfactory approach used mainly in mitral valve surgery with excellent results in many centers. Cardioplegia administration can be still a problem, especially when an endoaortic clamp is used. We retrospectively analyzed our early results with histidine-triptophane-ketoglutarate (HTK) solution used for myocardial protection in MICS. Methods: Between February 2003 and February 2004, 8 patients underwent mitral valve surgery using an endo- cardiopulmonary bypass (CPB) system and HTK solution as myocardial protection. The mean patient age was 67.7 9.2 years, and the preoperative ejection fraction was normal in all patients. Three patients had valve repair and 5 had valve replacement. Mean CPB time was 129.2 19.4 minutes, and aortic cross-clamp duration was 88.5 15.4 minutes. Results: In every case HTK solution was used for only a single dose for cardioplegia at the beginning of the procedure, without any recalls. The heart restarted spontaneously at reperfusion in 6 of 8 cases (75%), and there were no significant modifications in electrocardiogram results or myocardial cytonecrosis enzymes (creatine kinase and its MB fraction) during the postoperative period. Conclusions: HTK solution is a cold crystalloid cardioplegia solution that has demonstrated its utility in MICS because it provides a safe long cardioplegic arrest time and it reduces the risk of inadequate coronary perfusion due to dislodgement of the endoaortic clamp.

Mitral valve surgery using minimally invasive versus sternotomy approach – A propensity matched analysis

2012 ◽  
Vol 60 (S 01) ◽  
Author(s):  
A Cetinkaya ◽  
A Van Linden ◽  
M Schönburg ◽  
J Kempfert ◽  
M Tackenberg ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Mitral Valve Surgery ◽  
Valve Surgery

Fifteen Years of Minimally Invasive Mitral Valve Surgery: Single Centre Results in 1006 Patients

2016 ◽  
Vol 64 (S 01) ◽  
Author(s):  
N. Papadopoulos ◽  
A. Zierer ◽  
U. Stock ◽  
A. Miscovic ◽  
A. Karimian-Tabrizi ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Single Centre

Minimally invasive mitral valve surgery in octogenarians: Mid-term results

2007 ◽  
Vol 55 (S 1) ◽  
Author(s):  
J Seeburger ◽  
T Kuntze ◽  
V Falk ◽  
J Onnasch ◽  
M Czesla ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Mitral Valve Surgery ◽  
Valve Surgery ◽  
Surgery In Octogenarians ◽  
Mid Term Results
Sign in / Sign up

Export Citation Format

Share Document